January 2026 marked a pivotal inflection point with the launch of the Wegovy pill (oral semaglutide 25 mg), while Eli Lillys orforgliprona once-daily oral non-peptide GLP-1awaits FDA approval in Q2 2026
Luzeiro 1 1 Local Health Unit of Coimbra, Neurology, Coimbra, Portugal
Unlike traditional dieting methods that rely heavily on willpower, these treatments help biologically reduce hunger and increase feelings of fullness , making it easier to maintain a calorie deficit over time
Our medical team closely monitors each session to ensure your comfort and safety
Zoe: Look at us finding the perfect excuse to stock up on more lippies Michelle: One can never have too many lippies
As appropriate for the patient, we offer treatments like: Semaglutide and other GLP-1 agonists These medications regulate blood sugar, reduce appetite, slow the digestive process, and more